Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The onset of the therapeutic response to antidepressant treatment exhibits a characteristic delay. Animal models sensitive to chronic, but not acute, antidepressant treatment are greatly needed for studying antidepressant mechanisms. We initially assessed four inbred mouse strains for their behavioral response to chronic treatment with the selective-serotonin reuptake inhibitor fluoxetine (0, 5, 10 mg/kg/day in drinking water), which is used for the treatment of mood and anxiety disorders. Only the highly anxious BALB/c strain exhibited sensitivity to fluoxetine in the forced swim test. Additionally, fluoxetine reduced locomotion in C57BL/6 and 129SvEv, but not BALB/c and DBA/2, strains. We then evaluated the effects of subchronic (approximately 4 days) and chronic (approximately 24 days) fluoxetine treatment (0, 10, 18, 25 mg/kg/day) on measures of anxiety and depression in BALB/c mice. Anxiety measures were obtained using the open field and novelty-induced hypophagia tests. Antidepressant effects were evaluated using the forced swim test. We found 18 mg/kg/day of chronic fluoxetine to be active in all three paradigms; subchronic treatment had no effect. Anxiety-related measures were reduced by 18 mg/kg/day. In the forced swim test, 10 and 18 mg/kg/day increased swimming and reduced immobility. Here we present several novel effects of chronic, but not subchronic, antidepressant treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This dosage of 18 mg/kg/day have been shown to be in the upper range of the therapeutic dose of fluoxetine administered to humans.16”
From Synaptic Vesicle 2A (SV2A) Positron Emission Tomography (PET) Imaging as a Marker of Therapeutic Response in a Mouse Model of Depression (2025) · cites this paper as [16]
In the citing paper
“Hyponeophagia (novelty-suppressed feeding) has also been used to assess anxiety-like behavior in rodents; in a novel environment, hungry mice exhibit an increased latency to feed that is sensitive to benzodiazepines and SSRIs47,48.”
From Resolving the neural circuits of anxiety (2015) · cites this paper as [47]
In the citing paper
“The NIH paradigm is a sensitive measure for potential anxiolytic drugs and anxiogenic effects of withdrawal on both acute and extended drug administration paradigms (Dulawa et al., 2004;Dulawa and Hen, 2005).”
From Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors (2014) · cites this paper as Dulawa et al., 2004
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“We have previously shown that steady state for both fluoxetine and norfluoxetine is achieved by 5 days of receiving fluoxetine in the drinking water (10 mgskgsday), as serum levels after 5 or 90 days of treatment are equivalent (”
BackgroundSelf-citationBehavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 4,013
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
Prut, L., & Belzung, C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01272-x · Cited by 3,175
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832 · cited 1×
“The intake of palatable fluids, including sucrose and saccharin solutions, has been used as a measure of reward sensitivity (”
MethodAssessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551
Psychopharmacology: The Fourth Generation of Progress
Green, A. I. (1996) · Psychiatric Services · doi:10.1176/ps.47.3.312 · Cited by 1,145
Neuropsychopharmacology: The Fifth Generation of Progress
SAGDUYU, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,019
Pharmacokinetics of selective serotonin reuptake inhibitors
Hiemke, C., & Härtter, S. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00048-0 · Cited by 883
Antidepressants and neuroplasticity
D'Sa, C., & Duman, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01203.x · Cited by 513 · cited 1×
“These long-term effects are thought to involve increases in neural plasticity and growth-related events (”
Background
Research works printed but not linked: 2
- Hirschfeld R, Weisssman M (2002). Risk factors for major depression and bipolar disorder. In: Davis K, Charney D, Coyle J, Nemeroff C (eds). Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott Williams & Wilkins: Philadelphia. pp 1018–1025.
- Merikangas K, Pine D (2002). Genetic and other vulnerability factors for anxiety and stress disorders. In: Davis K, Charney D, Coyle J, Nemeroff C (eds). Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott Williams & Wilkins: Philadelphia. pp 868–882.
Cited by
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish
Egan, R. J., Bergner, C. L., Hart, P. C., Cachat, J. M., Canavello, P. R., Elegante, M. F., Elkhayat, S. I., Bartels, B. K., Tien, A. K., Tien, D. H., et al. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.022 · Cited by 1,376
“Behavioral and physiological data from this study agree strongly with that seen in previously published in rodent studies showing that chronic exposure to fluoxetine reduces anxiety [43,44], corticosterone responses (mice [44]) and HPA sensitivity (rats [45,46]).”
ResultGenetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior
Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., et al. (2006) · Science · doi:10.1126/science.1129663 · Cited by 1,340
David, D. J., Samuels, B. A., Rainer, Q., Wang, J.-W., Marsteller, D., Mendez, I., Drew, M., Craig, D. A., Guiard, B. P., Guilloux, J.-P., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.017 · Cited by 1,267
“Behavioral Testing Open Field This test was performed as described previously (Dulawa et al., 2004).”
MethodSelf-citationThe ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198
Cryan, J. F., Valentino, R. J., & Lucki, I. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.008 · Cited by 1,119
Forced swimming test in mice: A review of antidepressant activity
Petit-Demouliere, B., Chenu, F., & Bourin, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2048-7 · Cited by 1,003
“It showed several differences between chronic and subchronic treatment of a SSRI, fluoxetine, in the FST with BALB/c mice weighting 25–35 g (Dulawa et al. 2004).”
BackgroundMethodInfluentialResolving the neural circuits of anxiety
Calhoon, G. G., & Tye, K. M. (2015) · Nature Neuroscience · doi:10.1038/nn.4101 · Cited by 766
The Forced Swim Test as a Model of Depressive-like Behavior
Yankelevitch-Yahav, R., Franko, M., Huly, A., & Doron, R. (2015) · Journal of Visualized Experiments · doi:10.3791/52587 · Cited by 754
Can, A., Dao, D. T., Terrillion, C. E., Piantadosi, S. C., Bhat, S., & Gould, T. D. (2011) · Journal of Visualized Experiments · doi:10.3791/3769 · Cited by 526
Hippocampal Neurogenesis: Regulation by Stress and Antidepressants
Dranovsky, A., & Hen, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.082 · Cited by 663
“Out of these conflict-based tests, open field, novelty-induced hypophagia, and novelty-suppressed feeding were all shown to have a response specific to chronic antidepressant treatment (Bodnoff et al 1988; Dulawa et al 2004; Merali et al 2003; Santarelli et al 2003).”
BackgroundSelf-citationSchmidt, H. D., & Duman, R. S. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee2aa8 · Cited by 648
“(NIH) paradigm (Dulawa et al., 2004), have been used to study the biological mechanisms underlying the behavioral effects of chronic antidepressant administration.”
BackgroundAberrant light directly impairs mood and learning through melanopsin-expressing neurons
LeGates, T. A., Altimus, C. M., Wang, H., Lee, H.-K., Yang, S., Zhao, H., Kirkwood, A., Weber, E. T., & Hattar, S. (2012) · Nature · doi:10.1038/nature11673 · Cited by 577
“8), consistent with published reports 17 .”
Hill, A. S., Sahay, A., & Hen, R. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.85 · Cited by 557
“…effects of chronic CORT administration in different tests than observed here (David et al, 2009), we note that different strains of mice often display inconsistent behavioral phenotypes and responses to various stress models and drugs (Dulawa et al, 2004; Razzoli et al, 2011; Yalcin et al, 2008).”
BackgroundSelf-citationGould, T. D., Dao, D. T., & Kovacsics, C. E. (2009) · Neuromethods · doi:10.1007/978-1-60761-303-9_1 · Cited by 499
Jiang, W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25509 · Cited by 527
“Recent studies have further shown that chronic fluoxetine treatment produced antidepressant and anxiolytic effects (18, 19) and the anxiolytic effects are likely achieved by promoting hippocampal neurogenesis (18).”
BackgroundFactors influencing behavior in the forced swim test
Bogdanova, O. V., Kanekar, S., D'Anci, K. E., & Renshaw, P. F. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.05.012 · Cited by 464
Dulawa, S. C., & Hen, R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.017 · Cited by 430
Self-citationPeripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral Models
Schmidt, H. D., & Duman, R. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.114 · Cited by 403
“The NIH paradigm is considered a model of anxiety, and response time in this model is consistent with that for the therapeutic action of antidepressants (Dulawa and Hen, 2005; Dulawa et al , 2004).”
Holick, K. A., Lee, D. C., Hen, R., & Dulawa, S. C. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301399 · Cited by 310
“Due to limitations of the use of the NSF (challenges in the control of food deprivation, limited reliability), we have recently developed a new hyponeophagia paradigm, the novelty-induced hypophagia (NIH) (Dulawa et al, 2004; Dulawa and Hen, 2005).”
BackgroundMethodInfluentialSelf-citationCryan, J. F., Page, M. E., & Lucki, I. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0093-5 · Cited by 321
“Although antidepressants produce effects in the rat FST following either short-term or chronic treatment, it is uncertain whether antidepressants might produce different behavioral changes following chronic treatments compared to short-term effects (Caldarone et al. 2003; Dulawa et al. 2004; Kelliher et al. 2003; Rene…”
BackgroundInfluentialEarly-life stress has persistent effects on amygdala function and development in mice and humans
Malter Cohen, M., Jing, D., Yang, R. R., Tottenham, N., Lee, F. S., & Casey, B. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310163110 · Cited by 307
“To investigate the effects of ELS in mice, we used an analog of our human emotional “go/no-go” task (8, 32) by modifying the novelty-induced hypophagia paradigm (33).”
MethodAnsorge, M. S., Morelli, E., & Gingrich, J. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3973-07.2008 · Cited by 301
“The novelty-induced hypophagia test was performed as previously described (Dulawa et al., 2004).”
MethodLukić, I., Getselter, D., Ziv, O., Oron, O., Reuveni, E., Koren, O., & Elliott, E. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0466-x · Cited by 273
Siegmund, A., & Wotjak, C. T. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.017 · Cited by 269
“The doses were chosen according to other pharmacological studies in mice (Dulawa et al., 2004; Santarelli et al., 2003) and adjusted to the weight and fluid intake of the animals (group means).”
MethodTests of unconditioned anxiety — Pitfalls and disappointments
Ennaceur, A. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.05.032 · Cited by 259
“both acute and chronic treatment [114,116,158,293,325,361,362].”
Anxiety-Related Behaviors in Mice
Crawley, J., & Bailey, K. (2008) · Frontiers in Neuroscience · doi:10.1201/noe1420052343.ch5 · Cited by 267
Onishchenko, N., Karpova, N., Sabri, F., Castrén, E., & Ceccatelli, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05484.x · Cited by 263
Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior
Brachman, R. A., McGowan, J. C., Perusini, J. N., Lim, S. C., Pham, T. H., Faye, C., Gardier, A. M., Mendez-David, I., David, D. J., Hen, R., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.022 · Cited by 257
“Rodents given acute or chronic antidepressants exhibit decreased immobility (32).”
BackgroundSelf-citationGenetic variation in cortico-amygdala serotonin function and risk for stress-related disease
Holmes, A. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.006 · Cited by 264
“Interestingly, the BALB/cJ and DBA/2J strains also tend to exhibit higher levels of anxietylike behavior and stress-reactivity than C57BL/6J, and BALB/cJ also show greater sensitivity to the antidepressant-like effects of SRI's (Anisman et al., 2001; Belzung and Griebel, 2001; Dulawa et al., 2004).”
BackgroundThe role of serotonin receptor subtypes in treating depression: a review of animal studies
Carr, G. V., & Lucki, I. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2097-z · Cited by 260
“SSRIs, when administered chronically to rats and mice, are also able to produce an anxiolytic-like effect in these tests (Bechtholt et al. 2008; Bodnoff et al. 1988; Bodnoff et al. 1989; Dulawa et al. 2004).”
BackgroundMárquez, C., Poirier, G. L., Cordero, M. I., Larsen, M. H., Groner, A., Marquis, J., Magistretti, P. J., Trono, D., & Sandi, C. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.144 · Cited by 245
“The rats were submitted to a forced swimming test to evaluate depression-like behaviors.(31,34)”
MethodEtkin, A., Alarcón, J. M., Weisberg, S. P., Touzani, K., Huang, Y. Y., Nordheim, A., & Kandel, E. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.013 · Cited by 218
“Criterion was six consecutive correct choices, at which point the experiment ended and mice were refed ad lib. Novelty-Induced Hypophagia This test for anxiety was performed as previously described (Dulawa et al., 2004).”
MethodInhibition of the Serotonin (5-Hydroxytryptamine) Transporter Reduces Bone Accrual during Growth
Warden, S. J., Robling, A. G., Sanders, M. S., Bliziotes, M. M., & Turner, C. H. (2005) · Endocrinology · doi:10.1210/en.2004-1259 · Cited by 221
“The drug doses were chosen on the basis of previous reports of the antiimmobility effects of fluoxetine in mice (19, 26, 27).”
BackgroundMethodHare, B. D., Shinohara, R., Liu, R. J., Pothula, S., DiLeone, R. J., & Duman, R. S. (2019) · Nature Communications · doi:10.1038/s41467-018-08168-9 · Cited by 217
Xiao, J., Katsumata, N., Bernier, F., Ohno, K., Yamauchi, Y., Odamaki, T., Yoshikawa, K., Ito, K., & Kaneko, T. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200488 · Cited by 203
Perona, M. T. G., Waters, S., Hall, F. S., Sora, I., Lesch, K.-P., Murphy, D. L., Caron, M., & Uhl, G. R. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830cd80f · Cited by 201
“2003; Dulawa et al., 2004; Lucki and O’Leary, 2004; Crowley et al., 2005).”
BackgroundMethodInfluentialEarnheart, J. C., Schweizer, C., Crestani, F., Iwasato, T., Itohara, S., Mohler, H., & Lüscher, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3609-06.2007 · Cited by 203
“GABAergic developmental control of trait anxiety and behavioral inhibition Cell type-specific and developmentally controlled gene deletion was used to elucidate the molecular and cellular substrate underlying trait anxiety associated with a modest GABAAR deficit.”
MethodTo Approach or Avoid: An Introductory Overview of the Study of Anxiety Using Rodent Assays
La-Vu, M., Tobias, B. C., Schuette, P. J., & Adhikari, A. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00145 · Cited by 182
Zebrafish antipredatory responses: A future for translational research?
Gerlai, R. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.10.008 · Cited by 190
Brain mast cells link the immune system to anxiety-like behavior
Nautiyal, K. M., Ribeiro, A. C., Pfaff, D. W., & Silver, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809479105 · Cited by 167
“Selective serotonin reuptake inhibitors increase serotonin signaling and decrease anxiety (54, 55); therefore, a lack of mast cell derived serotonin may result in an increase in anxiety-like behaviors.”
BackgroundAdult Neurogenesis and Mental Illness
Schoenfeld, T. J., & Cameron, H. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.230 · Cited by 182
“Similarly, exercise in the form of voluntary wheel running also ameliorates depressive- and anxiety-like symptoms in naive animals (Duman et al, 2008; Schoenfeld et al, 2013) as well as in animal models of mental illness (Lapmanee et al, 2013; Maniam and Morris, 2010; Wolf et al, 2011).”
BackgroundGenetics of Affective and Anxiety Disorders
Leonardo, E. D., & Hen, R. (2006) · Annual Review of Psychology · doi:10.1146/annurev.psych.57.102904.190118 · Cited by 184
Self-citationKinsey, S. G., Bailey, M. T., Sheridan, J. F., Padgett, D. A., & Avitsur, R. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.11.001 · Cited by 190
Rodent models in depression research: Classical strategies and new directions
Pollak, D. D., Rey, C. E., & Monje, F. J. (2010) · Annals of Medicine · doi:10.3109/07853891003769957 · Cited by 187
Altered gene expression of histone deacetylases in mood disorder patients
Hobara, T., Uchida, S., Otsuki, K., Matsubara, T., Funato, H., Matsuo, K., Suetsugi, M., & Watanabe, Y. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.015 · Cited by 185
“First, we evaluated the antidepressant effects of clomipramine, paroxetine, lithium and valproate using the forced swim test, which is highly reliable and has a strong predictive validity for antidepressant compounds (Cryan et al., 2002; Dulawa et al., 2004; Porsolt et al., 1977).”
Evans, J., Sun, Y., McGregor, A., & Connor, B. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.012 · Cited by 184
Fluoxetine: a case history of its discovery and preclinical development
Perez-Caballero, L., Torres-Sanchez, S., Bravo, L., Mico, J. A., & Berrocoso, E. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.907790 · Cited by 178
“Although any or anxiogenic effects have been demonstrated in Wistar and Sprague--Dawley rats [83-85], a clear anxiolytic effect was seen in the open field, as well as novelty-induced hypophagia, in BALB/cJ mice [74].”
BackgroundInfluentialIdentifying fast-onset antidepressants using rodent models
Ramaker, M. J., & Dulawa, S. C. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.36 · Cited by 182
Self-citationNR2B-Dependent Plasticity of Adult-Born Granule Cells is Necessary for Context Discrimination
Kheirbek, M. A., Tannenholz, L., & Hen, R. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1692-12.2012 · Cited by 167
“Forced-swim test (FST), novelty suppressed feeding (NSF), and elevated plus maze (EPM) were conducted as previously described (Dulawa et al., 2004; David et al., 2009; Sahay et al., 2011a).”
MethodSelf-citationAn Animal Model of a Behavioral Intervention for Depression
Pollak, D. D., Monje, F. J., Zuckerman, L., Denny, C. A., Drew, M. R., & Kandel, E. R. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.041 · Cited by 166
“Forced-Swim Test The forced-swim test was carried out as described elsewhere (Dulawa et al., 2004).”
MethodDuman, C. H. (2010) · Vitamins and hormones · doi:10.1016/s0083-6729(10)82001-1 · Cited by 207
“Additionally strengthening the predictive validity is the fact that hyponeophagia paradigms can detect increased anxiety, including that resulting from acute SSRI treatment, an effect that is not reliably detected in other models but is clinically relevant (Dulawa and Hen, 2005).”
InfluentialFeeling Strained? Influence of Genetic Background on Depression-Related Behavior in Mice: A Review
Jacobson, L. H., & Cryan, J. F. (2007) · Behavior Genetics · doi:10.1007/s10519-006-9106-3 · Cited by 167
BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity
Bath, K. G., Jing, D. Q., Dincheva, I., Neeb, C. C., Pattwell, S. S., Chao, M. V., Lee, F. S., & Ninan, I. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.318 · Cited by 169
Sartori, S. B., Whittle, N., Hetzenauer, A., & Singewald, N. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.027 · Cited by 152
Fournier, N. M., & Duman, R. S. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.022 · Cited by 155
Kim, C. S., Chang, P. Y., & Johnston, D. (2012) · Neuron · doi:10.1016/j.neuron.2012.05.027 · Cited by 158
“In addition, mice chronically injected with fluoxetine displayed antidepressant-and anxiolytic-like behaviors (Dulawa et al., 2004), suggesting depression and anxiety might share common neural substrates.”
The lonely mouse: Verification of a separation-induced model of depression in female mice
Martin, A. L., & Brown, R. E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.10.006 · Cited by 171
How Stress and Fluoxetine Modulate Serotonin 2C Receptor Pre-mRNA Editing
Englander, M. T., Dulawa, S. C., Bhansali, P., & Schmauss, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3895-04.2005 · Cited by 153
“For example , Dulawa et al. (2004) showed that drug-naive BALB/c mice subjected to the same FST paradigm used in the present study spent less time swimming and more time passively floating compared with C57BL/6 mice and that chronic (but not acute) fluoxetine treatment significantly increased their…”
InfluentialSelf-citationNeurotrophins and Psychiatric Disorders
Castrén, E. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_17 · Cited by 150
Battery of behavioral tests in mice to study postoperative delirium
Peng, M., Zhang, C., Dong, Y., Zhang, Y., Nakazawa, H., Kaneki, M., Zheng, H., Shen, Y., Marcantonio, E. R., & Xie, Z. (2016) · Scientific Reports · doi:10.1038/srep29874 · Cited by 161
“The total distance travelled indicates the locomotor activity of the mice 16,17 .”
Ghrelin's Roles in Stress, Mood, and Anxiety Regulation
Chuang, J.-C., & Zigman, J. M. (2010) · International Journal of Peptides · doi:10.1155/2010/460549 · Cited by 135
“are not uncommon (as an example, in one study, only one out of four inbred strains of mice exhibited sensitivity to fluoxetine in the forced swim test [28]).”
BackgroundMargiotta‐Casaluci, L., Owen, S. F., Cumming, R. I., de Polo, A., Winter, M. J., Panter, G. H., Rand‐Weaver, M., & Sumpter, J. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110467 · Cited by 156
“The anxiolytic responses observed in fish are also in full agreement with the anxiolytic effects caused by fluoxetine treatment in rodents [48,49] and humans [23,24], confirming the high potentiality of fish models in translational biomedical sciences.”
BackgroundResultDavid, D. J. P., Klemenhagen, K. C., Holick, K. A., Saxe, M., Mendez‐David, I., Santarelli, L., Craig, D. A., Zhong, H., Swanson, C. J., Hegde, L. G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.109678 · Cited by 147
“Male BALB/cJ mice (Jackson Laboratories, Bar Harbor, ME) were used for the FST and the L/D studies because of their high sensitivity to chronic antidepressant treatment in these models (Belzung and Griebel, 2001; Dulawa et al., 2004).”
BackgroundMethodInfluentialSelf-citationGould, G. G., Hensler, J. G., Burke, T. F., Benno, R. H., Onaivi, E. S., & Daws, L. C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07104.x · Cited by 139
Gold nanoclusters for Parkinson's disease treatment
Gao, G., Chen, R., He, M. X., Li, J., Li, J., Wang, L., & Sun, T. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.12.013 · Cited by 147
Pham, T. H., Mendez-David, I., Defaix, C., Guiard, B. P., Tritschler, L., David, D. J., & Gardier, A. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.010 · Cited by 136
“The BALB/cJ strain of mice was chosen for its baseline anxiety phenotype (Dulawa et al., 2004).”
InfluentialA standardization of the Novelty-Suppressed Feeding Test protocol in rats
Blasco‐Serra, A., González-Soler, E. M., Cervera‐Ferri, A., Teruel‐Martí, V., & Valverde‐Navarro, A. A. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.08.019 · Cited by 141
Wong, R. Y., Oxendine, S. E., & Godwin, J. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-348 · Cited by 142
“Similar to rodents, highly inbred lines of zebrafish show differences in baseline levels of stress and anxiety as well as responses to anxiolytics [2,4,11,12,36,37].”
InfluentialThe age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review
Olivier, J. D. A., Blom, T., Arentsen, T., & Homberg, J. R. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.09.013 · Cited by 131
“For instance, it has been shown that chronic fluoxetine treatment in BALB/c mice increased the time spent in the center of the open field and reduced the latency and increased the consumption of a palatable meal in the novelty-induced hypophagia test (Dulawa et al., 2004).”
BackgroundPham, T. H., Defaix, C., Xu, X., Deng, S.-X., Fabresse, N., Alvarez, J.-C., Landry, D. W., Brachman, R. A., Denny, C. A., & Gardier, A. M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.020 · Cited by 131
Li, N., Wang, Q., Wang, Y., Sun, A., Lin, Y., Jin, Y., & Li, X. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00266 · Cited by 128
“Fluoxetine was made up fresh daily in saline solution, and the dose administered was 18 mg/kg by daily oral gavage (Dulawa et al., 2004).”
MethodIdentification of the Cortical Neurons that Mediate Antidepressant Responses
Schmidt, E. F., Warner-Schmidt, J. L., Otopalik, B. G., Pickett, S. B., Greengard, P., & Heintz, N. (2012) · Cell · doi:10.1016/j.cell.2012.03.038 · Cited by 125
“We chose the selective serotonin reuptake inhibitor (SSRI) fluoxetine (FLX) because it is one of the most highly prescribed antidepressants and is known to have antidepressant activity in rodent models of depression (Cryan et al., 2005; Dulawa et al., 2004).”
Kara, N., Stukalin, Y., & Einat, H. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.11.003 · Cited by 133
“Some previous studies suggest that acute effects can be reached only with high doses compared with chronic administration (Dulawa et al., 2004) but the general practice of using acute administration as initially done when the FST was developed (Porsolt et al.”
BackgroundDuman, C. H., Schlesinger, L., Terwilliger, R., Russell, D. S., Newton, S. S., & Duman, R. S. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.016 · Cited by 123
“The ability of IGF-I to specifically decrease consumption latencies in the novel environment is similar to the effect of chronic antidepressant administration in this test [18], (Fig.”
ResultImmature Dentate Gyrus: An Endophenotype of Neuropsychiatric Disorders
Hagihara, H., Takao, K., Walton, N. M., Matsumoto, M., & Miyakawa, T. (2013) · Neural Plasticity · doi:10.1155/2013/318596 · Cited by 123
Guilloux, J.-P., Mendez-David, I., Pehrson, A., Guiard, B. P., Repérant, C., Orvoën, S., Gardier, A. M., Hen, R., Ebert, B., Miller, S., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.014 · Cited by 115
Self-citationDepression‐Related Behavioral Tests
Powell, T. R., Fernandes, C., & Schalkwyk, L. C. (2012) · Current Protocols in Mouse Biology · doi:10.1002/9780470942390.mo110176 · Cited by 111
“…are required to show a significant reduction in latency to NSF. Tricylic antidepressants (Bodnoff et al., 1988), SSRIs (Santarelli et al., 2003; Dulawa et al., 2004), and atypical antidepressants (Merali et al., 2003) are all required in chronic doses in order to elicit a reduction in latency.”
BackgroundMeyer, U., Spoerri, E., Yee, B. K., Schwarz, M. J., & Feldon, J. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn131 · Cited by 115
“were selected based on previous drug administration protocols using regular drinking bottles in mice.(31,32) HAL was obtained from Janssen-Cilag (Baar, Switzerland) in the form of ampoules consisting of 5 mg of HAL in 1 ml of solvent containing minimal amounts of lactic acid; it was further diluted in regular tap wate…”
MethodBhansali, P., Dunning, J., Singer, S. E., David, L., & Schmauss, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4632-06.2007 · Cited by 114
“Consistent with the results of Dulawa et al. (2004), chronic fluoxetine treatment of adult SFR mice significantly decreased their passive behavioral response to the FST, and chronic adolescent fluoxetine treatment of these mice exerted a similar, albeit somewhat weaker effect (Fig.”
BackgroundMethodResultInfluentialThe adverse skeletal effects of selective serotonin reuptake inhibitors
Tsapakis, E. M., Gamie, Z., Tran, G. T., Adshead, S., Lampard, A., Mantalaris, A., & Tsiridis, E. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2010.10.006 · Cited by 110
“Moreover, administration of 10 mg/kg/day of fluoxetine in mice resulted in similar plasma fluoxetine levels at the lower range of that found in humans taking 20–80 mg/day [15].”
BackgroundDavid, D. J., Wang, J., Samuels, B. A., Rainer, Q., David, I., Gardier, A. M., & Hen, R. (2010) · The Neuroscientist · doi:10.1177/1073858409360281 · Cited by 108
Self-citationAlboni, S., Poggini, S., Garofalo, S., Milior, G., El Hajj, H., Lecours, C., Girard, I., Gagnon, S., Boisjoly-Villeneuve, S., Brunello, N., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.07.155 · Cited by 111
“According to previous studies, such intake allows to reach an effective fluoxetine serum level approximating 150 ng/ml (Dulawa et al., 2004).”
Role of the Astroglial Glutamate Exchanger xCT in Ventral Hippocampus in Resilience to Stress
Nasca, C., Bigio, B., Zelli, D., de Angelis, P., Lau, T., Okamoto, M., Soya, H., Ni, J., Brichta, L., Greengard, P., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.020 · Cited by 113
“…associated with CRS over the same time course of administration (Figure 4C) in agreement with previous findings showing that longer time course of weeks of administration with fluoxetine to CRS mice are required to induce antidepressant-like effects (Dulawa et al., 2004; Nasca et al., 2014, Soc.”
ResultEffects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety
Gundersen, B. B., & Blendy, J. A. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.04.008 · Cited by 112
“…inhibitors and tricyclic antidepressants have been shown to reduce latency to consume in the novel environment after similar lengths of treatment, which have led to use of this paradigm as a model of chronic antidepressant response (Dulawa et al., 2004; Gur et al., 2007; Merali et al., 2003).”
BackgroundSelf-citationShishkina, G. T., Kalinina, T. S., & Дыгало, Н. Н. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.017 · Cited by 113
Effects of fluoxetine on the swimming and behavioural responses of the Arabian killifish
Barry, M. J. (2012) · Ecotoxicology · doi:10.1007/s10646-012-1036-7 · Cited by 122
“Fluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI) used to treat depression and anxiety disorders (Dulawa et al. 2004), and one of the most widely prescribed psycho-active drugs in the developed world (Mennigen et al. 2011; Winder et al. 2012).”
BackgroundTanti, A., Westphal, W.-P., Girault, V., Brizard, B., Devers, S., Leguisquet, A.-M., Surget, A., & Belzung, C. (2013) · Hippocampus · doi:10.1002/hipo.22134 · Cited by 106
“Additionally, serum fluoxetine levels following chronic treatment with both these doses (Dulawa et al., 2004) were found to be toward the bottom and the high end, respectively, of plasma concentrations found in patients taking 20–80 mg/day fluoxetine (Koran et al., 1996), which is the clinical…”
BackgroundKarlsson, R., Choe, J. S., Cameron, H. A., Thorsell, A., Crawley, J. N., Holmes, A., & Heilig, M. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0945-2 · Cited by 115
“These tests are validated for their sensitivity to the acute and chronic effects of antidepressants such as fluoxetine, respectively (Cryan and Holmes 2005; Dulawa et al. 2004), and to that extent suggest an increases in “depressionrelated” behavior in Y1R −/− mice.”
BackgroundMethodInfluentialBranchi, I., Santarelli, S., Capoccia, S., Poggini, S., D’Andrea, I., Cirulli, F., & Alleva, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062226 · Cited by 102
“with saccharin) drunk by treated mice allowed to reach an effective FLX serum level around 150 ng/ml, as shown in previous studies [39].”
Wang, Y., Neumann, M., Hansen, K., Hong, S. M., Kim, S., Noble-Haeusslein, L. J., & Liu, J. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1648 · Cited by 101
“Chronic fluoxetine treatment reduces depression via both neurogenesis-dependent and neurogenesis-independent mechanisms (David et al., 2009; Dulawa et al., 2004; Holick et al., 2008; Santarelli et al., 2003).”
BackgroundDentate gyrus neurogenesis and depression
Sahay, A., Drew, M. R., & Hen, R. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)63038-6 · Cited by 116
“Latency-tofeed is decreased by chronic AD drug treatment and acute anxiolytic treatment, but not by acute AD drug treatment (Bodnoff et al., 1989; Dulawa et al., 2004).”
BackgroundSelf-citationSerotonin 2C receptor antagonists induce fast-onset antidepressant effects
Opal, M. D., Klenotich, S. C., Morais, M., Bessa, J., Winkle, J., Doukas, D., Kay, L. J., Sousa, N., & Dulawa, S. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.144 · Cited by 103
Self-citationKantak, P. A., Bobrow, D. N., & Nyby, J. G. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000013 · Cited by 100
“In addition, this strain responds well to SRI treatment in blocking the OCD-like effects of RU 24969 (Dulawa et al., 2004; Shanahan et al., 2011).”
BackgroundShanahan, N. A., Holick Pierz, K. A., Masten, V. L., Waeber, C., Ansorge, M., Gingrich, J. A., Geyer, M. A., Hen, R., & Dulawa, S. C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.026 · Cited by 102
“Drug doses were selected based on the results of previous dose response studies (21,30).”
BackgroundMethodSelf-citationLukić, I., Getselter, D., Koren, O., & Elliott, E. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00123 · Cited by 102
Selective serotonin reuptake inhibitors as a novel class of immunosuppressants
Gobin, V., Van Steendam, K., Denys, D., & Deforce, D. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.02.030 · Cited by 101
“15 times higher than the plasma concentration obtained after a chronic dose of 18 mg/kg (the latter dose gives rise to a plasma concentration within the same range as those found in patients) [81].”
Breuillaud, L., Rossetti, C., Meylan, E. M., Mérinat, C., Halfon, O., Magistretti, P. J., & Cardinaux, J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.011 · Cited by 111
Serotonin regulation of behavior via large-scale neuromodulation of serotonin receptor networks
Salvan, P., Fonseca, M., Winkler, A. M., Beauchamp, A., Lerch, J. P., & Johansen-Berg, H. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01213-3 · Cited by 101
A brain-wide functional map of the serotonergic responses to acute stress and fluoxetine
Grandjean, J., Corcoba, A., Kahn, M. C., Upton, A. L., Deneris, E. S., Seifritz, E., Helmchen, F., Mansuy, I. M., Mann, E. O., Rudin, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08256-w · Cited by 101
Metadata
- Authors
- Dulawa, S. C., Holick, K. A., Gundersen, B., & Hen, R.
- Affiliations
- Columbia University (US)
- Venue
- Neuropsychopharmacology
- Published
- 2004-04-07
- Volume
- 29
- Issue
- 7
- Pages
- 1321-1330
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1987972424
- Cited by
- 671
- References
- 50
- Citations by year
- 2026: 16 · 2025: 21 · 2024: 27 · 2023: 28 · 2022: 32 · 2021: 32 · 2020: 31 · 2019: 51 · 2018: 31 · 2017: 42 · 2016: 34 · 2015: 42 · 2014: 41 · 2013: 44 · 2012: 28
- FWCI
- 9.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression (MH068542-1)
- National Institutes of Health (5r01da009862-08, 5f32mh065791-02)
- National Institute of Mental Health (F32-MH65791-01A1, P50MH050733, P50-MH50733, R01 MH068542-1, R01MH068542)
- National Institute on Drug Abuse (R01 DA09862)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- fluoxetine, chronic antidepressant treatment, anxiety, depression, selective serotonin reuptake inhibitors, inbred mouse strains, BALB/c mice, forced swim test, novelty-induced hypophagia, locomotor activity, antidepressant sensitivity
- MeSH terms
- Analysis of Variance, Animals, Anxiety, Behavior, Animal, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Administration Schedule, Exploratory Behavior, Fluoxetine, Immobilization, Male, Mice, Inbred Strains, Motor Activity, Reaction Time, Species Specificity, Swimming, Time Factors, Selective Serotonin Reuptake Inhibitors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.